Determining and Comparing the Real-World Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized With COVID-19

CONCLUSION: In conclusion, our findings suggest that similar to nirmatrelvir-ritonavir, molnupiravir has a distinct potential role in COVID-19 treatment, transcending its current perceived status as only a secondary option.PMID:38374626 | PMC:PMC10876432 | DOI:10.3346/jkms.2024.39.e52
Source: Journal of Korean Medical Science - Category: Biomedical Science Authors: Source Type: research